Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED
- 30 October 2024
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (6) , 1537-1549
Abstract
Context: Soluble immune checkpoints play an important role in peripheral tolerance that has seldom been investigated in Graves' disease (GD) and thyroid eye disease (TED). Objective: The objective of this work is to examine the alteration of soluble immune checkpoints in GD and TED. Methods: We performed a quantitative multiplex analysis of 17 immune checkpoint proteins in serum from 50 GD patients without TED, 28 GD patients with TED, and 40 healthy controls. The association with demographic, serologic, clinical features and 27 cytokines was analyzed. A follow-up was conducted in GD patients without TED. Functional outcomes of sLAG-3 and sGITR were assessed in cell cultures using rh-LAG3, rh-GITR, an antagonistic LAG-3 antibody, and an antagonistic GITR antibody. Results: GD Patients with TED had distinct sICP and cytokine profiles compared with GD patients without TED. Active patients with TED exhibited elevation in the levels of sBTLA, sLAG-3, sGITR, sCD80, sCD86, and sPD-L1. Further, GD patients without TED with high sBTLA, sCD27, and sCD40 levels at baseline showed a better improvement in thyrotropin receptor antibody titers after antithyroid drug treatment. Adding recombinant human GITR and LAG-3 to peripheral blood mononuclear cell cultures resulted in increased inflammatory cytokine secretion and decreased anti-inflammatory cytokine secretion. Conclusion: The present study uncovers disturbed soluble immune checkpoints and cytokines in GD patients with and without TED and may pave the way for novel immunological screening, allowing for identification of patients with TED at higher risk of developing active disease and patients with GD a better treatment response after antithyroid drug treatment.Keywords
Funding Information
- National Natural Science Foundation of China (82100826, 82100836, 82170803)
- Science and Technology Program of Guangzhou, China (202201011020, 202201011532)
- Young Talent Support Project of Guangzhou Association for Science and Technology
This publication has 61 references indexed in Scilit:
- Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive childrenDiabetologia, 2024
- Single cell transcriptomic analysis of Graves’ disease thyroid glands reveals the broad immunoregulatory potential of thyroid follicular and stromal cells and implies a major re-interpretation of the role of aberrant HLA class II expression in autoimmunityJournal of Autoimmunity, 2023
- Increased plasma levels of soluble programmed death ligand 1 (sPD-L1) and fibroblast growth factor 23 (FGF-23) in patients with Graves’ ophthalmopathy in comparison to hyperthyroid patients without Graves’ ophthalmopathyCytokine, 2023
- The CD14++CD16+ monocyte subset is expanded and controls Th1 cell development in Graves' diseaseClinical Immunology, 2022
- High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune diseaseDiabetologia, 2022
- Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory studyJournal of Endocrinological Investigation, 2018
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune RegulationImmunity, 2016
- Risk Factors for Developing Thyroid-Associated Ophthalmopathy Among Individuals With Graves DiseaseJAMA Ophthalmology, 2015
- AAV–sBTLA facilitates HSP70 vaccine-triggered prophylactic antitumor immunity against a murine melanoma pulmonary metastasis model in vivoCancer Letters, 2014
- Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibodyJournal of Autoimmunity, 2006